Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells
To produce marine-origin nanoparticles (NPs) aiming to develop more effective and tolerated therapies for breast cancer. NPs based in two marine-origin polymers (fucoidan and chitosan) were prepared by polyelectrolyte complexation, for the delivery of an antitumor drug model (gemcitabine [Gem]). Fin...
Saved in:
Published in | Nanomedicine (London, England) Vol. 13; no. 16; pp. 2037 - 2050 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Future Medicine Ltd
01.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To produce marine-origin nanoparticles (NPs) aiming to develop more effective and tolerated therapies for breast cancer.
NPs based in two marine-origin polymers (fucoidan and chitosan) were prepared by polyelectrolyte complexation, for the delivery of an antitumor drug model (gemcitabine [Gem]).
Final formulation resulted in stable NPs around 115-140 nm in size and with a polydispersity index less than 0.2. Gem was encapsulated at a maximum entrapment efficiency of 35-42%. Drug-release studies demonstrated that around 84% of Gem is released within 4 h. Cytotoxicity results of Gem-loaded NPs showed increased toxicity (around 25%) when compared with free Gem.
The drug-loaded NPs present increased toxicity over human breast cancer cells without increasing toxic effects over endothelial cells. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1743-5889 1748-6963 1748-6963 |
DOI: | 10.2217/nnm-2018-0004 |